Results 101 to 110 of about 39,654 (197)

JAK2V617F mediates resistance to DNA damage-induced apoptosis by modulating FOXO3A localization and Bcl-xL deamidation. [PDF]

, 2016
The JAK2V617F mutation is found in most patients with a myeloproliferative neoplasm (MPN). This gain-of-function mutation dysregulates cytokine signaling and is associated with increased accumulation of DNA damage, a process likely to drive disease ...
Ahn, JS, Chen, E, Green, AR, Kent, DG, Li, J, Park, HJ   +5 more
core  

Blood cell activation in myeloproliferative neoplasms

, 2009
Francisco Cervantes, Eduardo Arellano‐Rodrigo, Alberto Álvarez‐Larrán   +2 more
openalex   +2 more sources

Prevalence and prognostic impact of allelic imbalances associated with leukemic transformation of Philadelphia chromosome–negative myeloproliferative neoplasms [PDF]

, 2010
Nils H. Thoennissen, Utz Krug, Dhong Hyun Tony Lee, Norihiko Kawamata, Gabriela B. Iwanski, Terra L. Lasho, Tamara Weiss, Daniel Nowak, Maya Koren‐Michowitz, Motohiro Kato, Masashi Sanada, Lee‐Yung Shih, Arnon Nagler, Sophie Raynaud, Carsten Müller‐Tidow, Ruben A. Mesa, Torsten Haferlach, D. Gary Gilliland, Ayalew Tefferi, Seishi Ogawa, H. Phillip Koeffler   +20 more
openalex   +1 more source

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

, 2009
Francesco Passamonti, Francisco Cervantes, Alessandro M. Vannucchi, Enrica Morra, Elisa Rumi, Arturo Pereira, Paola Guglielmelli, Ester Pungolino, Marianna Caramella, Margherita Maffioli, Cristiana Pascutto, Mario Lazzarino, Mario Cazzola, Ayalew Tefferi   +13 more
openalex   +1 more source

Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML

, 2009
A Tefferi, Ken‐Hong Lim, Omar Abdel‐Wahab, Lasho Tl, Jay Patel, Patnaik Mm, CA Hanson, Animesh Pardanani, DG Gilliland, Ross L. Levine   +9 more
openalex   +2 more sources

Deactylase inhibition in myeloproliferative neoplasms [PDF]

, 2010
Sridurga Mithraprabhu, George Grigoriadis, Tiffany Khong, Andrew Spencer   +3 more
openalex   +1 more source

Oncogenic Signals as Treatment Targets in Classic Myeloproliferative Neoplasms

, 2009
Ayalew Tefferi, Ross L. Levine, Hagop M. Kantarjian   +2 more
openalex   +1 more source

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms [PDF]

, 2011
Luca Malcovati, Elli Papaemmanuil, David Bowen, Jacqueline Boultwood, Matteo Giovanni Della Porta, Cristiana Pascutto, Erica Travaglino, Michael J. Groves, Anna L. Godfrey, Ilaria Ambaglio, Anna Gallì, Matteo C. Da Vià, Simona Conte, Sudhir Tauro, Norene Keenan, Ann Hyslop, Jonathan Hinton, Laura Mudie, James S. Wainscoat, P. Andrew Futreal, Michael R. Stratton, Peter J. Campbell, Eva Hellström‐Lindberg, Mario Cazzola   +23 more
openalex   +1 more source

Outcomes for ruxolitinib only versus combination with interferon in treating patients with myelofibrosis

Blood Neoplasia
Katie Erdos, Aya Alshareef, Richard T. Silver, Joseph M. Scandura, Ghaith Abu-Zeinah   +4 more
doaj   +1 more source

Prodromal myeloproliferative neoplasms: The 2008 WHO classification

, 2009
Hans Michael Kvasnicka, Jüergen Thiele
openalex   +1 more source